RAD — Radiopharm Theranostics Balance Sheet
0.000.00%
- AU$87.50m
- AU$56.47m
- AU$3.63m
- 14
- 22
- 86
- 35
Annual balance sheet for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.027 | 27 | 11.7 | 18.6 | 29.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.006 | 0.056 | 4.47 | 0.987 | 10.4 |
| Total Other Current Assets | |||||
| Total Current Assets | 0.033 | 27.3 | 16.3 | 22.8 | 39.9 |
| Net Property, Plant And Equipment | — | 0.002 | 0.068 | 0.061 | 0.053 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.033 | 83.4 | 74.9 | 72 | 86.5 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.158 | 7.88 | 13.2 | 17.6 | 14.9 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.158 | 20.4 | 30.6 | 43.9 | 41.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.125 | 63 | 44.4 | 28.1 | 44.8 |
| Total Liabilities & Shareholders' Equity | 0.033 | 83.4 | 74.9 | 72 | 86.5 |
| Total Common Shares Outstanding |